USA 2022
COI 0.98 %
Breed relevant health information:
Canine Multifocal Retinopathy 3 (CMR3)
N/N (clear)
Degenerative myelopathy (DM)
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
USA 2015
COI 1.17 %
Breed relevant health information:
Elbows
normal
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
-
25/5/2016
Hips
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
-
2/5/2018
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
25/5/2016
Other health issues and screening results:
Patella
normal
-
1/5/2018
Degenerative myelopathy (DM)
N/mut (carrier)
-
25/5/2016
|
USA 2012
COI 2.83 %
*
Breed relevant health information:
Canine Multifocal Retinopathy 3 (CMR3)
N/N (clear)
-
9/3/2017
Degenerative myelopathy (DM)
N/N (clear)
-
9/3/2017
Elbows
normal
-
8/1/2014
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
-
9/3/2017
Hips
Fair / B1 / 4-6 / B / 11-18
-
8/1/2014
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
9/3/2017
Other health issues and screening results:
Patella
normal
-
8/1/2014
|
|
USA 2008
COI 0.36 %
*
Breed relevant health information:
Elbows
normal
-
7/9/2011
Hips
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
-
7/9/2011
|
|||
|
FIN 1998
COI 4.39 %
*
Breed relevant health information:
Hips
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
-
14/5/2007
Year of death:
2014
|
||
FIN 2001
COI 3.72 %
*
Breed relevant health information:
Hips
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
|
|||
USA 2018
COI 1.98 %
Breed relevant health information:
Elbows
normal
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
|
FIN 2010
COI 3.67 %
*
Breed relevant health information:
Elbows
normal
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
FIN 2001
COI 6.79 %
*
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
FIN 2007
COI 5.47 %
*
Breed relevant health information:
Elbows
normal
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|||
FIN 2013
COI 4.20 %
Breed relevant health information:
Elbows
normal
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
FIN 2011
COI 3.67 %
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
-
2/4/2012
|
||
FIN 2008
COI 1.41 %
*
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
-
15/10/2010
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Sugarok The Dark Knight
|
13 Feb 2015 | normal | N/N (clear) | Good / A2 / 1-3 / A / 5-10 (no >6/hip) | N/N (clear) | |||||
Elbows:
normal
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Sugarok Beyond the North Wind
|
23 Dec 2018 | normal | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | |||||||
Elbows:
normal
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
|
||||||||||
Siblings | ||||||||||
Forest Trail Knight of Hyperborea
|
23 Apr 2022 | N/N (clear) | N/N (clear) | N/N (clear) | N/N (clear) | |||||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Forest Trail Starry Starry Knight
|
23 Apr 2022 | N/N (clear) | N/mut (carrier) | N/N (clear) | N/mut (carrier) | |||||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Degenerative myelopathy (DM):
N/mut (carrier)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/mut (carrier)
|
||||||||||
ForestTrail@Knight East of the Sun West of the Moon
|
23 Apr 2022 | N/N (clear) | N/N (clear) | N/N (clear) | N/N (clear) | |||||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
ForestTrail@Knight Midst The Riphean Mountains
|
23 Apr 2022 | N/N (clear) | N/N (clear) | N/N (clear) | N/N (clear) | |||||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Half siblings (sire) | ||||||||||
Sugarok Celtic's MidKnight Moon Over Paris
|
12 May 2019 | N/N (clear) | N/N (clear) | N/N (clear) | N/N (clear) | |||||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Sugarok Knight's Romance
|
12 May 2019 | N/N (clear) | N/N (clear) | N/N (clear) | ||||||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Sugarok Lovin Midknight To First Light
|
12 May 2019 | N/N (clear) | N/mut (carrier) | normal | N/N (clear) | Good / A2 / 1-3 / A / 5-10 (no >6/hip) | N/N (clear) | |||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Degenerative myelopathy (DM):
N/mut (carrier)
Elbows:
normal
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Sugarok Mid Summer Knight's Dream
|
12 May 2019 | N/N (clear) | N/N (clear) | N/N (clear) | ||||||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Sugarok One Knight In Paris
|
12 May 2019 | N/N (clear) | N/N (clear) | N/N (clear) | N/N (clear) | |||||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Degenerative myelopathy (DM):
N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Half siblings (dam) | ||||||||||
Offspring |